name | 张有 |
sex | male
|
age | 48 岁 |
hospital number | 537905 |
height | 170 cm |
weight | 70 kg |
BSA | 1.81 m2 |
APACHEⅡ | 34 分 |
Infection source | lung
/blood
|
date | 2017/12/21 年/月/日 |
Sequential Organ Failure Assessment | 15 分 |
Fluid resuscitation |
age>=60 | no
|
septic shock | yes
|
mechanical ventilation | trachea cannula
|
Early fluid resuscitation | yes
|
age<60 | yes
|
Pregnant woman | no
|
advanced malignant tumor | no
|
Pulmonary interstitial fibrosis | no
|
Serious arrhythmia | no
|
Small Tidal Volume Ventilation | no
|
Liver failure | no
|
Refuse to participate | no
|
Heart disease | no
|
yes
|
|
no
|
|
no
|
|
no
|
|
- vital signs
- Blood Gas Analysis
- vasoactive agent and fluid
- PiCCO parameters
- Cardiac Ultrasound
- lung ultrasound
- inferior vena cava
yes
|
|
比阿培南+万古霉素 |
|
vasoactive agent | norepinephrine
/dopamine
/epinephrine
|
120 min |
|
min |
|
1620 min |
Temperature | 36.8 ℃ |
Heart Rate | 87 次/分 |
Breath | 16 次/分 |
Systolic pressure (SP) | 152 mmHg |
Diastolic pressure | 81 mmHg |
mean arterial pressure | 96 mmHg |
Pcv-aCO2 | 8 mmHg |
DO2 | 790.4 |
VO2 | 242.5 |
Ca-vO2 | 52.5 |
pH value | 7.2 |
PaO2 | 122 mmHg |
PaCO2 | 35 mmHg |
BE | -13.2 mmol/L(±2.3mmol/L) |
SaO2 | 98 % |
Blood lactic acid concentration, LAC | 3.8 mmol/L |
Oxygenation index (PaO2/FiO2) | 203.3 mmHg |
pH value | 7.16 |
PcvO2 | 448 mmHg |
PcvCO2 | 43 mmHg |
BE | -12.7 mmol/L |
ScvO2 | 68 % |
Volume of input | 0 ml |
Volume of output | 0 ml |
Volume of urine | 0 ml |
ultrafiltration volume | 0 ml |
norepinephrine | yes
|
Norepinephrine Dosage | 10 μg/Kg/min |
dopamine | yes
|
Dopamine Dosage | 20 μg/Kg/min |
Dobutamine | No
|
Dobutamine Dosage | μg/Kg/min |
Epinephrine
|
CVP | 20 mmHg |
cardiac output | 4.62 L/min |
cardiac index | 2.55 L/min/m2 |
stroke volume | 53.1 ml |
Stroke Index | 29.1 ml/m2 |
ITBVI | 794 ml/m2 |
GEDVI | 635 ml/m2 |
EVLWI | 8.4 ml/kg |
PVPI | 1.9 |
SVRI | 2387 DSm2/cm5 |
CFI | 4.1 |
GEF | 19 % |
SVV | % |
PPV | % |
dPmax | 17.4 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
the number of B line | 56 条 |
LUS | 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 2.4 mm |
IVC(expiratory phase) | 2.45 mm |
respiratory variations of inferior vena cavae diameter | 2 % |
2.4 mm |
|
mm |
|
2.5 mm |
|
mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 36.8 ℃ |
Heart Rate | 80 次/分 |
Breath | 16 次/分 |
Systolic Pressure | 153 mmHg |
Diastolic Pressure | 79 mmHg |
Mean Arterial Pressure | 95 mmHg |
Pcv-aCO2 | 6 mmHg |
DO2 | 738.4 |
VO2 | 196.4 |
Ca-vO2 | 40.2 |
PH value | 7.37 |
PaO2 | 96 mmHg |
PaCO2 | 35 mmHg |
BE | -4.6 mmol/L |
SaO2 | 98 % |
Blood Lactic Acid Concentration | 6.6 mmol/L |
Oxygenation index (PaO2/FiO2) | 160 mmHg |
PH value | 7.32 |
PcvO2 | 39 mmHg |
PcvCO2 | 41 mmHg |
BE | -4.4 mmol/L |
ScvO2 | 72 % |
Volume of input | 1130 ml |
Volume of output | 1500 ml |
Volume of urine | 60 ml |
Ultrafiltration Volume | 1200 ml |
Norepinephrine Dosage | 32 mg |
Dopamine Dosage | 360 mg |
Epinephrine Dosage | 5 mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | mg |
Levosimendan | no
|
CVP | 15 mmHg |
cardiac output | 4.88 L/min |
cardiac index | 2.7 L/min/m2 |
stroke volume | 61 ml |
Stroke Index | 2.7 ml/m2 |
ITBVI | 807 ml/m2 |
GEDVI | 646 ml/m2 |
EVLWI | 6.5 ml/kg |
PVPI | 1.5 |
SVRI | 2373 DSm2/cm5 |
CFI | 4.3 |
GEF | 22 % |
SVV | 11 % |
PPV | % |
dPmax | 1958 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 28 条 |
LUS | 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 2.2 mm |
IVC(expiratory phase) | 2.4 mm |
Respiratory variations of inferior vena cavae diameter | 8.6 % |
2.0 mm |
|
mm |
|
2.2 mm |
|
mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 36.6 ℃ |
Heart Rate | 93 次/分 |
Breath | 16 次/分 |
Systolic Pressure | 117 mmHg |
Diastolic Pressure | 54 mmHg |
Mean Arterial Pressure | 69 mmHg |
Pcv-aCO2 | 7 mmHg |
DO2 | 959.5 |
VO2 | 216.1 |
Ca-vO2 | 32.3 |
PH value | 7.43 |
PaO2 | 96 mmHg |
PaCO2 | 36 mmHg |
BE | -0.4 mmol/L |
SaO2 | 98 % |
Blood Lactic Acid Concentration | 5.8 mmol/L |
Oxygenation index (PaO2/FiO2) | 160 mmHg |
PH value | 7.38 |
PcvO2 | 40 mmHg |
PcvCO2 | 43 mmHg |
BE | -0.3 mmol/L |
ScvO2 | 76 % |
Volume of input | 2260 ml |
Volume of output | 3020 ml |
Volume of urine | 120 ml |
Ultrafiltration Volume | 2400 ml |
Norepinephrine Dosage | 60 mg |
Dopamine Dosage | 720 mg |
Epinephrine Dosage | 10 mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | mg |
Levosimendan |
CVP | 18 mmHg |
cardiac output | 6.69 L/min |
cardiac index | 3.7 L/min/m2 |
stroke volume | 71.9 ml |
Stroke Index | 39.7 ml/m2 |
ITBVI | 824 ml/m2 |
GEDVI | 659 ml/m2 |
EVLWI | 7.0 ml/kg |
PVPI | 1.6 |
SVRI | 1103 DSm2/cm5 |
CFI | 5.7 |
GEF | 25 % |
SVV | 8 % |
PPV | % |
dPmax | 1814 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 46 条 |
LUS | 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 2.0 mm |
IVC(expiratory phase) | 2.4 mm |
Respiratory variations of inferior vena cavae diameter | 18 % |
2.0 mm |
|
mm |
|
2.2 mm |
|
mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 36.6 ℃ |
Heart Rate | 99 次/分 |
Breath | 16 次/分 |
Systolic Pressure | 112 mmHg |
Diastolic Pressure | 65 mmHg |
Mean Arterial Pressure | 77 mmHg |
Pcv-aCO2 | 10 mmHg |
DO2 | 560.6 |
VO2 | 113.9 |
Ca-vO2 | 26 |
PH value | 7.46 |
PaO2 | 118 mmHg |
PaCO2 | 42 mmHg |
BE | 5.3 mmol/L |
SaO2 | 99 % |
Blood Lactic Acid Concentration | 2.9 mmol/L |
Oxygenation index (PaO2/FiO2) | 236 mmHg |
PH value | 7.4 |
PcvO2 | 43 mmHg |
PcvCO2 | 52 mmHg |
BE | 6.1 mmol/L |
ScvO2 | 79 % |
Volume of input | 4520 ml |
Volume of output | 6130 ml |
Volume of urine | 230 ml |
Ultrafiltration Volume | 4800 ml |
Norepinephrine Dosage | 100 mg |
Dopamine Dosage | 1200 mg |
Epinephrine Dosage | 20 mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | mg |
Levosimendan |
CVP | 8 mmHg |
cardiac output | 4.39 L/min |
cardiac index | 2.43 L/min/m2 |
stroke volume | 44.3 ml |
Stroke Index | 24.5 ml/m2 |
ITBVI | 495 ml/m2 |
GEDVI | 397 ml/m2 |
EVLWI | 4.5 ml/kg |
PVPI | 1.7 |
SVRI | 2275 DSm2/cm5 |
CFI | 6.2 |
GEF | 26 % |
SVV | 11 % |
PPV | % |
dPmax | 1337 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 16 条 |
LUS | 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 1.8 mm |
IVC(expiratory phase) | 2.2 mm |
Respiratory variations of inferior vena cavae diameter | 20 % |
1.6 mm |
|
mm |
|
2.0 mm |
|
mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 36.6 ℃ |
Heart Rate | 94 次/分 |
Breath | 18 次/分 |
Systolic Pressure | 123 mmHg |
Diastolic Pressure | 69 mmHg |
Mean Arterial Pressure | 83 mmHg |
Pcv-aCO2 | 6 mmHg |
DO2 | 782.4 |
VO2 | 258.4 |
Ca-vO2 | 35 |
PH value | 7.46 |
PaO2 | 72 mmHg |
PaCO2 | 37 mmHg |
BE | 2.5 mmol/L |
SaO2 | 94 % |
Blood Lactic Acid Concentration | 2.5 mmol/L |
Oxygenation index (PaO2/FiO2) | 144 mmHg |
PH value | 7.42 |
PcvO2 | 34 mmHg |
PcvCO2 | 43 mmHg |
BE | 2.8 mmol/L |
ScvO2 | 63 % |
Volume of input | 9292 ml |
Volume of output | 10070 ml |
Volume of urine | 370 ml |
Ultrafiltration Volume | 8400 ml |
Norepinephrine Dosage | 200 mg |
Dopamine Dosage | 1800 mg |
Epinephrine Dosage | 20 mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | mg |
Levosimendan |
CVP | 14 mmHg |
cardiac output | 7.38 L/min |
cardiac index | 4.08 L/min/m2 |
stroke volume | 78.5 ml |
Stroke Index | 43.4 ml/m2 |
ITBVI | 811 ml/m2 |
GEDVI | 649 ml/m2 |
EVLWI | 8.2 ml/kg |
PVPI | 1.8 |
SVRI | 1353 DSm2/cm5 |
CFI | 6.4 |
GEF | 28 % |
SVV | 21 % |
PPV | % |
dPmax | 1633 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 70 条 |
LUS | 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 2.0 mm |
IVC(expiratory phase) | 2.3 mm |
Respiratory variations of inferior vena cavae diameter | 14 % |
2.1 mm |
|
mm |
|
2.3 mm |
|
mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 37.2 ℃ |
Heart Rate | 137 次/分 |
Breath | 16 次/分 |
Systolic Pressure | 135 mmHg |
Diastolic Pressure | 87 mmHg |
Mean Arterial Pressure | 104 mmHg |
Pcv-aCO2 | 8 mmHg |
DO2 | 796.1 |
VO2 | 76 |
Ca-vO2 | 10.2 |
PH value | 7.43 |
PaO2 | 72 mmHg |
PaCO2 | 42 mmHg |
BE | 3.1 mmol/L |
SaO2 | 95 % |
Blood Lactic Acid Concentration | 1.7 mmol/L |
Oxygenation index (PaO2/FiO2) | 144 mmHg |
PH value | 7.38 |
PcvO2 | 38 mmHg |
PcvCO2 | 50 mmHg |
BE | -7.9 mmol/L |
ScvO2 | 86 % |
Volume of input | 12666 ml |
Volume of output | 14760 ml |
Volume of urine | 530 ml |
Ultrafiltration Volume | 12000 ml |
Norepinephrine Dosage | 280 mg |
Dopamine Dosage | 2600 mg |
Epinephrine Dosage | 20 mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | mg |
Levosimendan |
CVP | 8 mmHg |
cardiac output | 7.43 L/min |
cardiac index | 4.1 L/min/m2 |
stroke volume | 54.2 ml |
Stroke Index | 30.0 ml/m2 |
ITBVI | 1135 ml/m2 |
GEDVI | 908 ml/m2 |
EVLWI | 10.7 ml/kg |
PVPI | 1.7 |
SVRI | 1870 DSm2/cm5 |
CFI | 4.6 |
GEF | 15 % |
SVV | % |
PPV | % |
dPmax | 984 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 72 条 |
LUS | 分 |
B+ Zone | 区 |
IVC(expiratory phase) | 2.4 mm |
Respiratory variations of inferior vena cavae diameter | 2.4 % |
IVC(inspiratory phase) | 0 mm |
2.5 mm |
|
mm |
|
2.5 mm |
|
mm |
- Cardiac Function Indices
- Renel Function Indices
- Blood Routine Tests
- Sequential Organ Failure Assessment
NT-proBNP | pg/ml |
BNP | 830 pg/ml |
cTNI | ng/ml |
Creatine kinase isoenzyme, CKMB | U/L |
Creatinine | 342 umol/L |
Urea nitrogen | 15.2 mmol/l |
MDRD | ml/min/1.73m2 |
Date of examination | yyyy-mm-dd |
WBC | 8.1 X10*9/L |
neutrophilic granulocyte percentage | 87.8 % |
Hb | 130 g/L |
CRP | 122.64 mg/L |
Procalcitonin, PCT | 大于100 ng/ml |
Date of test |
|
Sequential Organ Failure Assessment | 15 分 |
- Cardiac Function Indices
- Renel Function Indices
- Blood Routine Tests
- Sequential Organ Failure Assessment
NT-proBNP | pg/ml |
BNP | 901 pg/ml |
cTNI | ng/ml |
Creatine kinase isoenzyme, CKMB | U/L |
Creatinine | 303 umol/L |
Urea nitrogen | 12 mmol/l |
MDRD | ml/min/1.73m2 |
WBC | 14.9 X10*9/L |
neutrophilic granulocyte percentage | 90.2 % |
Hb | 96 g/L |
CRP | 357.53 mg/L |
Procalcitonin, PCT | 大于100 ng/ml |
Sequential Organ Failure Assessment | 15 分 |
- Cardiac Function Indices
- Renel Function Indices
- Blood Routine Tests
- Sequential Organ Failure Assessment
NT-proBNP | pg/ml |
BNP | 431 pg/ml |
cTNI | ng/ml |
Creatine kinase isoenzyme, CKMB | U/L |
Creatinine | 291 umol/L |
Urea nitrogen | 9.4 mmol/L |
MDRD | ml/min/1.73m2 |
WBC | 11.7 X10*9/L |
neutrophilic granulocyte percentage | 88.4 % |
Hb | 84 g/L |
CRP | 351.21 mg/L |
Procalcitonin, PCT | 大于100 ng/ml |
Sequential Organ Failure Assessment | 15 分 |
Transfusion of Red Cells | no
|
Transfusion of Red Cells | U |
Plasma infusion | yes
|
Plasma infusion | 1000 ml |
platelet transfusion | no
|
platelet transfusion | U |
APACHEⅡ | 34 分 |
Complication |
prognosis | die
|
28-day mortality | yes
|
survival time(day) | 天 |
death time | yyyy/mm/dd |
diagnosis of death |
|
length of stay | 5 天 |
duration in ICU | 5 天 |
duration of mechanical ventilation | 120 小时 |
ICU expenses | 56710 元 |
Continuous Renal Replacement Therapy | yes
|
Continuous Renal Replacement Therapy | 400 小时 |